Helen Higley

Statistics

Publications

Citations

102

H-Index

Active since

2008

Affiliations

Bristol-Myers Squibb (United States)(Current)

Helen Higley is an author at Bristol-Myers Squibb (United States) specializing in antiretroviral therapy, antiviral pharmacology, and antiviral agents.

Publications per year

2008–2020

Publications

Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors

B. Narasimhulu Naidu, Margaret E. Sorenson, Manoj Patel et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 48 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +14

Entecavir Exhibits Inhibitory Activity against Human Immunodeficiency Virus under Conditions of Reduced Viral Challenge

Pin‐Fang Lin, Beata Nowicka-Sans, Brian Terry et al. · Antimicrobial Agents and Chemotherapy · 2008 · 29 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

The discovery and preclinical evaluation of BMS-707035, a potent HIV-1 integrase strand transfer inhibitor

B. Narasimhulu Naidu, Michael Walker, Margaret E. Sorenson et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 15 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +11

Design, synthesis and SAR study of bridged tricyclic pyrimidinone carboxamides as HIV-1 integrase inhibitors

Manoj Patel, B. Narasimhulu Naidu, Ira B. Dicker et al. · Bioorganic & Medicinal Chemistry · 2020 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–4 of 4